| Paul Rowe became a Partner in the Litigation Department at Wachtell, Lipton, Rosen and Katz in 1985. He focuses on representing corporations and directors in litigation involving M&A transactions, proxy contests, class actions involving allegations of breach of fiduciary duty, and federal securities claims. Mr. Rowe has written extensively on subjects relating to fiduciary duties and other corporation and securities law issues, most recently in "Pills, Polls and Professors: A Reply to Professor Gilson", co-authored with Martin Lipton and in the Delaware Journal of Corporate Law, 2002, vol. 1. In recent years, Mr. Rowe has been prominent in various high-profile M&A litigations, representing Novartis in its litigations arising out of its acquisition in Alcon; representing Goldman Sachs in litigation arising out of the buy-out of Kinder Morgan Inc.; representing Wells Fargo in litigation arising out of its purchase of Wachovia Corp.; and Rohm & Haas in its litigation to require Dow Chemical to close its acquisition agreement.
Mr. Rowe received an A.B. degree, magna cum laude, from Harvard University in 1976, where he was a member of Phi Beta Kappa. He graduated from Harvard Law School in 1979 with a J.D. degree, magna cum laude. Mr. Rowe was a member of The Harvard Law Review from 1977-1979 and after law school, Mr. Rowe was a law clerk to the Honorable J. Edward Lumbard of the United States Court of Appeals for the Second Circuit. In 1997-98, Mr. Rowe was an Adjunct Professor of Law at the University of Pennsylvania Law School, teaching a course on mergers and acquisitions. |
